Obeticholic acid for fatty liver

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Nov 2024: Trial registered, NCT06691412

The trials

NCT06691412: Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes

State
Not started
Phase
Phase 3
People
100 planned
Started
15 Nov 2024
Primary completion
1 Jan 2026
Arms
the group will receive obeticholic acid
Results
None posted
  1. 15 Nov 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Obeticholic Acid 5 mg.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.